These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37344166)

  • 21. Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective.
    Nguyen TTT; Kim YT; Jeong G; Jin M
    Exp Mol Med; 2024 Mar; 56(3):559-569. PubMed ID: 38448692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spectrum of hemophagocytic lymphohistiocytosis: a retrospective study comparing adult macrophage activation syndrome to malignancy-associated hemophagocytic lymphohistiocytosis.
    Good SD; Wade SD; Kyttaris VC
    Rheumatol Int; 2022 Jul; 42(7):1247-1255. PubMed ID: 35015099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine Storm and Sepsis-Induced Multiple Organ Dysfunction Syndrome.
    Carcillo JA; Shakoory B
    Adv Exp Med Biol; 2024; 1448():441-457. PubMed ID: 39117832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
    Nakanuma S; Gabata R; Okazaki M; Seki A; Hosokawa K; Yokoyama T; Katano K; Sugita H; Tokoro T; Takada S; Makino I; Taniguchi T; Harada K; Yagi S
    Transplant Proc; 2023 Oct; 55(8):1946-1950. PubMed ID: 37537076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW
    Arthritis Rheumatol; 2023 Oct; 75(10):1714-1732. PubMed ID: 37486733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists.
    Carter-Febres M; Lozano-Chinga M; Thomsen W; Treemarcki EB; James KE; Fluchel M
    J Pediatr; 2023 Apr; 255():65-71.e6. PubMed ID: 36328191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L; Carcillo J
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.
    Lee BJ; Cao Y; Vittayawacharin P; É'Leima G; Rezk S; Reid J; Brem EA; Ciurea SO; Kongtim P
    Eur J Haematol; 2023 Sep; 111(3):477-484. PubMed ID: 37385631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
    Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
    Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.
    Griffin G; Shenoi S; Hughes GC
    Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101515. PubMed ID: 32387063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
    Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
    J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.
    He L; Yao S; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
    Front Immunol; 2022; 13():955523. PubMed ID: 36189240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etoposide Therapy of Cytokine Storm Syndromes.
    Henter JI; von Bahr Greenwood T
    Adv Exp Med Biol; 2024; 1448():525-551. PubMed ID: 39117837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
    Bindoli S; Galozzi P; Doria A; Sfriso P
    Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
    Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
    J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome.
    Taylor ML; Hoyt KJ; Han J; Benson L; Case S; Chandler MT; Chang MH; Platt C; Cohen EM; Day-Lewis M; Dedeoglu F; Gorman M; Hausmann JS; Janssen E; Lee PY; Lo J; Priebe GP; Lo MS; Meidan E; Nigrovic PA; Roberts JE; Son MBF; Sundel RP; Alfieri M; Yeun JC; Shobiye DM; Degar B; Chang JC; Halyabar O; Hazen MM; Henderson LA
    J Rheumatol; 2022 Sep; 49(9):1042-1051. PubMed ID: 35840156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen.
    Xu G; Islam ST; Makarie-Rofail L; Barnsley L; Limaye S
    Int J Rheum Dis; 2023 Nov; 26(11):2284-2287. PubMed ID: 37150523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.